Kohima, January 24 (NEx): Globally, the COVID-19 deaths crossed the 2 million mark and more than 96 million people have been infected across the globe. Number of cases declined the past week but deaths have increased from previous weeks.
A weekly bulletin from the Health & Family welfare department, Integrated Disease Surveillance Programme said that Western Mediterranean region, Africa and Western Pacific regions have reported increase in number of cases (WHO situation reports). USA, Brazil and United Kingdom reported the maximum cases. While, SARS COV 2 Variants continue to be reported in more countries, the WHO has convened global meetings on the emerging variants of SARS COV 2 to improve surveillance and control measures.
More than 60 million doses have been administered across the globe as per Bloomberg COVID-19 Vaccine tracker in 55 countries including India. In the first week, India has vaccinated more than 10 lakh Health care workers (10,43, 534) with two vaccines- COVISHIELD and COVAXIN.
USA, CHINA, EU and UK have administered the maximum number of doses till date but Israel has inoculated the maximum doses per 100 people (37/ 100 people as per Bloomberg).
Vaccination offers the safest way to cut short the pandemic and reduce mortality. The need for vaccination is more urgently felt in the threat of emergence of many SARS COV 2 Variants as more transmission will lead to emergence of more variants which are poorly understood. The goal is to achieve maximum immunity of the population through vaccines and maintenance of COVID-19 appropriate behaviors at the same time.
Adverse Events Following Immunisation (AEFI):
As with all other vaccines and injectables, a small fraction of the beneficiaries will experience mild fever, pain at injection site, body ache, lethargy, head ache etc which will subside in a day or two or with medicines like paracetamol. These symptoms are just the body reacting to the vaccine and is normal. The same is observed even in routine Immunization of children. No long term side effects are expected as these
vaccines are proven established technologies. Both vaccines do not have the live virus and will not cause infection too.
Vaccine Doses And Protection:
Everyone will receive two doses of the vaccine 28 days apart. The full protection of the vaccine will be seen only after 42 days from the first dose. This necessitates the need for COVID-19 appropriate behaviors even after receiving the vaccine.
Who Should Not Receive The Vaccine?
a. Anyone with history of anaphylactic or allergic reaction to previous dose of COVID-19 vaccine.
b. History of immediate or delayed onset allergic reaction / anaphylaxis to vaccines or other injectable therapies, pharmaceutical products, food items etc.
c. Pregnant and lactating women
d. Below 18 years of age
e. Those having ACTIVE COVID-19 infection
f. COVID-19 patients who have received immunotherapy
g. Those who are acutely unwell and hospitalized for any medical condition.
*Pregnant mothers, lactating mothers and those below 18 years of age are not recommended for the COVID-19
vaccine since no clinical trials have been done for the mentioned categories and age groups. It is out of abundant precaution.
Everyone apart from the mentioned exceptions should eagerly take the vaccine when the time comes (including COVID-19 recovered patients), the health ministry noted.